Drug Markets/Miglitol

Miglitol

3 NDCs across 1 manufacturer|3 Generic,0 Brand

Miglitol is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 18, 1996, and the first generic was approved Feb 24, 2015. In 2024, Medicare Part D spent $495K on Miglitol across 1,658 claims for 419 beneficiaries.

Miglitol is available as 3 NDCs from 1 manufacturer (3 generic, 0 brand), with NADAC prices from $1.75 to $2.03 per EAa 16% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

3G / 0B

Manufacturers

1

competing in market

Price Spread

$1.75 – $2.03

per EA

7d Activity

3 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing MIGLITOL

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

What is Miglitol used to treat?

Miglitol is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.

When did Miglitol become available as a generic?

FDA approved the first generic Miglitol (ANDA) on Feb 24, 2015.

How much does Medicare spend on Miglitol?

In 2024, Medicare Part D spent $495K on Miglitol across 1,658 claims for 419 beneficiaries.

How many Miglitol products are on the market?

The Miglitol drug market contains 3 NDCs from 1 manufacturer — 3 generic and 0 brand products.

What is the price range for Miglitol?

NADAC reference prices for Miglitol range from $1.7545 to $2.0312 per EA — a 16% difference between cheapest and most expensive.

Which manufacturers make Miglitol?

1 manufacturer lists Miglitol in NADAC. Ranked by number of NDCs, the largest are Westminster Pharmaceuticals LLC (3).